Stock Performance and Market Context
On 26 Feb 2026, Trident Texofab Ltd opened sharply lower by 4.99%, immediately trading at its intraday low of Rs.79, a level not seen in the past year. The stock has consistently traded below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish momentum. This decline contrasts with the broader market, where the Sensex opened 142.71 points higher and was trading at 82,439.46, up 0.2% on the day. The Sensex remains within 4.51% of its 52-week high of 86,159.02, supported by gains in mega-cap stocks.
Trident Texofab’s underperformance is stark when compared to the Sensex’s 10.51% gain over the last year. The stock has generated a negative return of 55.30% during the same period, reflecting challenges specific to the company and its sector.
Financial Metrics and Ratings
The company’s Mojo Score currently stands at 23.0, with a Mojo Grade of Strong Sell, an upgrade from a previous Sell rating on 3 Feb 2026. This downgrade reflects concerns about the company’s long-term financial health and market position. The Market Cap Grade is rated 4, indicating a relatively modest market capitalisation within its peer group.
Trident Texofab’s financial ratios highlight some of the pressures it faces. The average Return on Capital Employed (ROCE) is 6.88%, which is considered weak for sustaining growth and profitability in the competitive garments and apparels industry. Additionally, the company’s Debt to EBITDA ratio is elevated at 6.83 times, signalling a limited capacity to comfortably service its debt obligations.
Recent Quarterly Results
The company reported flat net sales in the December 2025 quarter, with the lowest quarterly sales figure recorded at Rs.25.74 crores. This stagnation in revenue growth adds to the concerns about the company’s ability to generate consistent top-line momentum.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Long-Term and Sectoral Performance
Over the last three years, Trident Texofab has consistently underperformed the BSE500 index, as well as its sector peers. The stock’s negative returns over one year and three months further underline the challenges faced by the company in maintaining competitive positioning within the garments and apparels industry.
Valuation and Profitability Considerations
Despite the subdued price performance, the company’s valuation metrics present a mixed picture. The ROCE for the latest period is slightly improved at 7.4%, and the enterprise value to capital employed ratio stands at an attractive 1.8. This suggests that the stock is trading at a discount relative to its peers’ historical valuations.
Profitability has shown some positive signs, with reported profits rising by 122.5% over the past year. The company’s Price/Earnings to Growth (PEG) ratio is 0.8, indicating that earnings growth is not fully reflected in the current share price. However, these factors have not yet translated into a reversal of the stock’s downward trajectory.
Shareholding Pattern
The majority of Trident Texofab’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics. Institutional participation remains limited, reflecting cautious sentiment towards the stock.
Is Trident Texofab Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Key Metrics
To summarise, Trident Texofab Ltd’s stock has declined to Rs.79, marking a 52-week low and reflecting a sustained period of negative returns. The company’s financial indicators point to weak capital efficiency and elevated leverage, while recent sales figures have remained subdued. Although valuation metrics suggest the stock is trading at a discount, the overall market and sector context have not favoured a recovery in share price.
Meanwhile, the broader market environment remains positive, with the Sensex near its 52-week high and supported by gains in mega-cap stocks. This divergence highlights the specific challenges faced by Trident Texofab within the garments and apparels sector.
Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today
